Mirum Pharmaceuticals (MIRM) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Mirum Pharmaceuticals, Inc. (MIRM) reported $148.93 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 49.8%. EPS of -$0.11 for the same period compares to -$0.49 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $141.27 million, representing a surprise of +5.42%. The company delivered an EPS surprise of -650%, with the consensus EPS estimate being $0.02.While investors closely watch year-over-year changes in headline numbers -- revenu ...